Home » Miyares’ office investigating pharmacy benefit managers, manufacturers over insulin prices

Miyares’ office investigating pharmacy benefit managers, manufacturers over insulin prices

Virginia Attorney General Jason Miyares announced Tuesday that his office is looking into whether several insulin manufacturers and pharmacy benefit managers artificially inflated costs of diabetic medications.  Pharmacy benefits managers act as intermediaries between health plans, drug manufacturers and pharmacies. They retain rebates and discounts from contracts, but some consumers and pharmacies have said they […]

Virginia Attorney General Jason Miyares at the Virginia Capitol during the 2022 legislative session. (Photo by Ned Olive/Virginia Mercury)
Virginia Attorney General Jason Miyares announced Tuesday that his office is looking into whether several insulin manufacturers and pharmacy benefit managers artificially inflated costs of diabetic medications. 

Pharmacybenefitsmanagersactasintermediariesbetweenhealthplans,drugmanufacturersandpharmacies.Theyretainrebatesanddiscountsfromcontracts,butsomeconsumersandpharmacieshavesaidtheyareunsurehowmuchsavingsarebeingpassedon.InthecasesthatMiyares’officeisinvestigating,thequestionisifcertainPBMsanddrugproducersraisedcostsin